All proposals must be submitted in accordance with the requirements specified in the funding opportunity and in the Proposal & Award Policies & Procedures Guide (PAPPG) and its supplements. All NSF ...
Someone used A.I. to write my biography. Thousands more of those books are polluting Amazon. Who is behind all this drivel? Credit...Ahmed Gaber for The New York Times Supported by By Kashmir Hill ...
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey ...
Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...
Whether you're new to Tinder or the app has been taking up storage space on your phone for years, feeling pressure to start a conversation on Tinder or come up with good Tinder bio ideas is what ...
The school sitcom has found new life on Netflix after being canceled not once but twice during its original run Ron Batzdorff/NBCU Photo Bank/NBCUniversal via Getty A.P. Bio may have been canceled two ...
The biotech company has developed a climate-friendly fertilizer, and farmers are buying it. Pivot Bio is using genetically edited microbes to deliver just the right amount of nitrogen to crops, ...
When you’ve settled into your seat for a Broadway show, what’s the first thing you do after you’ve been handed your program? (Besides ticking off the “How Many Have You Seen?” pages, of course.) You ...
Dren Bio's platform is designed to activate myeloid cells by engaging a phagocytotic receptor that is only expressed on those cells. (wildpixel/iStock/Getty Images Plus) Novartis has had some bad luck ...
NEW YORK, June 26, 2024 /PRNewswire/ -- Formation Bio, a tech-driven and AI-native pharma company, announced today that it has raised $372MM of Series D financing. The financing was led by a16z with ...